Omeros Corporation today announced an update on its progress toward planned resubmission of its biologics license application ("BLA") for narsoplimab, the company's first-in-class antibody targeting ...
It will also complement other initiatives for young graduates in entrepreneurship, teaching, ICT, and similar forward-thinking fields, the NSA boss indicated. “These pillars, which serve as the ...
GLP-1 RAs to assist with weight loss have exploded in popularity. Researchers are working to identify which patients will benefit from them and their associated risks.
In a moment of historic and diplomatic significance, the President of the Republic of Seychelles is set to make the first official visit to Ghana, symbolizing the deepening bondRead ...